Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction

Medical Hypotheses

Volumn 82, Issue 1, 2014, Pages 36-39

  Mikolasevic, I ^a   Racki, S ^a   Lukenda, V ^b   Pavletic Persic, M ^a   Milic, S ^a   Orlic, L ^a  

^a KBC RIJEKA   (Croatia)

^b DR JOSIP BEN EVI GENERAL HOSPITAL   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CHYMOSIN; CYTOKINE;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; ENZYME ACTIVATION; GRAFT FAILURE; GRAFT RECIPIENT; HEPATITIS; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN RESISTANCE; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; METABOLIC SYNDROME X; MORBIDITY; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; POPULATION; RENAL GRAFT DYSFUNCTION; RENAL TRANSPLANT RECIPIENT; STEATOSIS;

CARDIOVASCULAR DISEASES; FATTY LIVER; HUMANS; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PRIMARY GRAFT DYSFUNCTION; RENIN-ANGIOTENSIN SYSTEM;

EID: 84890886616     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.10.030     Document Type: Article

References (27)

1. Elahi T., Akhtar F., Ahmed E., et al. Prevalence of metabolic syndrome in renal transplant recipients - a single center experience. J Pak Med Assoc 2009, 59:533-536.
2. Ravindran V., Baboolal K., Moore R. Post transplant diabetes mellitus after renal transplantation: the emerging clinical challenge. Yonsei Med J 2004, 45:1059-1064.
3. Jardine A.G., Gaston R.S., Fellstrom B.C., Holdaas H. Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet 2011, 378:1419.
4. Mikolasevic I., Jelic I., Sladoje-Martinovic B., et al. Metabolic disorders in renal transplant recipients. Acta Med Croatica 2012, 66:235-241.
5. Heisel O., Heisel R., Balshaw R., et al. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 2004, 4:583.
6. Ponticelli C., Cucchiari D., Graziani G. Hypertension in kidney transplant recipients. Transpl Int 2011, 24:523-533.
7. Midtvedt K., Hartmann A. Hypertension after kidney transplantation: are treatment guidelines emerging?. Nephrol Dial Transplant 2002, 17:1166-1169.
8. Gore J.L., Pham P.T., Danovitch G.M., et al. Obesity and outcome following renal transplantation. Am J Transplant 2006, 6:357.
9. Cheung C.Y., Chan H.W., Liu Y.L., et al. Prevalence of metabolic syndrome in Chinese renal transplant recipients. Hong Kong Med J 2008, 14:379-384.
10. Cervera-Lizardi J., Zapata-Aguilar D. Nonalcoholic fatty liver disease and its association with cardiovascular disease. Ann Hepatol 2009, 8(1):S40-S43.
11. Kim C.H., Younossi Z.M. Non alcoholic fatty liver disease: a manifestation of metabolic syndrome. Cleve Clin J Med 2008, 75:721-728.
12. Chalasani N., Younossi Z., Lavine J.E., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Disease, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012, 55:2005-2023.
13. Farrel G.C., Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006, 43:S99-S112.
14. Hamad A.A., Khalil A.A., Connolly V., et al. Relationship between non-alcoholic fatty liver disease and kidney function: a communication between two organs that needs further exploration. Arab J Gastroenterol 2012, 13:161-165.
15. Yasui K., Sumida Y., Mori Y., et al. Nonalcoholic steatohepatitis and increased risk of chronic kidney disease. Metabolism 2011, 60:735-739.
16. Targher G., Bertolini L., Rodella S., et al. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol 2010, 5(2166-71):999.
17. Marcen R. Cardiovascular risk factors in renal transplantation - current controversies. Nephrol Dial Transplant 2006, 21(Suppl. 3):iii3-iii8.
18. Hricik D. Metabolic syndrome in kidney transplantation: management of risk factors. Clin J Am Soc Nephrol 2011, 6:1781-1785.
19. Oruc M., Koseoglu K., Seyahi N., et al. Progression of metabolic syndrome in renal transplant recipients. Transplant Proc 2013, 45:3273-3278.
20. Rajman I., Harper L., McPake D., et al. Low-density lipoprotein sub-fraction profiles in chronic renal failure. Nephrol Dial Transplant 1998, 13:2281-2287.
21. Hjelmesaeth J., Hartmann A., Midtvedt K., et al. Metabolic cardiovascular syndrome after renal transplantation. Nephrol Dial Transplant 2001, 16:1047-1052.
22. Targher G., Marra F., Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenom?. Diabetologia 2008, 1947-1953.
23. Kiberd B.A. Cardiovascular disease in kidney transplant recipients. Adv Stud Med 2007, 7:169-178.
24. Yilmaz Y., Alahdab Y.O., Yonal O., et al. Microalbuminuria in non-diabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis. Metabolism 2010, [epub ahead of print].
25. Dowman J.K., Tomlinson J.W., Newsome P.N. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2011, 33:525-540.
26. Soveri I., Abedini S., Holdaas H., et al. Graft loss risk in renal transplant recipients with metabolic syndrome: subgroup analyses of the ALERT trial. J Nephrol 2012, 25:245-254.
27. Targher G., Chonchol M., Zoppini G., et al. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?. J Hepatol 2011, 54:1020-1029.